IFNG and familial pancreatic carcinoma: Finally, when identical amounts of IFN-γ from the supernatants of NK cells were used to differentiate OSCSC tumors, those from pancreatic cancer patients’ NK cells were less effective in differentiating OSCSC tumors as compared to those from healthy donors’ NK cells (Supplementary Figure S8).